Molecular mechanisms of programmed cell death and potential targeted pharmacotherapy in ischemic stroke (Review)
Authors:
Open Access
- 6 May 2025
- journal article
- review article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 56 (1) , 1-21
Abstract
Stroke poses a threat to the elderly, being the second leading cause of death and the third leading cause of disability worldwide. Ischemic stroke (IS), resulting from arterial occlusion, accounts for ~85% of all strokes. The pathophysiological processes involved in IS are intricate and complex. Currently, tissue plasminogen activator (tPA) is the only Food and Drug Administration‑approved drug for the treatment of IS. However, due to its limited administration window and the risk of symptomatic hemorrhage, tPA is applicable to only ~10% of patients with stroke. Additionally, the reperfusion process associated with thrombolytic therapy can further exacerbate damage to brain tissue. Therefore, a thorough understanding of the molecular mechanisms underlying IS‑induced injury and the identification of potential protective agents is critical for effective IS treatment. Over the past few decades, advances have been made in exploring potential protective drugs for IS. The present review summarizes the specific mechanisms of various forms of programmed cell death (PCD) induced by IS and highlights potential protective drugs targeting different PCD pathways investigated over the last decade. The present review provides a theoretical foundation for basic research and insights for the development of pharmacotherapy for IS.Keywords
This publication has 239 references indexed in Scilit:
- Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector moleculeNature Immunology, 2000
- Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathwaysCell Research, 2000
- Caspase-8 and Caspase-3 Are Expressed by Different Populations of Cortical Neurons Undergoing Delayed Cell Death after Focal Stroke in the RatThe Journal of Neuroscience, 1999
- Loss of NF-κB Activity during Cerebral Ischemia and TNF CytotoxicityMolecular Medicine, 1999
- Emerging roles of caspase-3 in apoptosisCell Death & Differentiation, 1999
- Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in miceActa Neuropathologica, 1998
- Regional Differences in Late-Onset Iron Deposition, Ferritin, Transferrin, Astrocyte Proliferation, and Microglial Activation after Transient Forebrain Ischemia in Rat BrainJournal of Cerebral Blood Flow & Metabolism, 1995
- Shigella flexneri induces apoptosis in infected macrophagesNature, 1992
- Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children.Radiology, 1988
- Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue KineticsBritish Journal of Cancer, 1972